Skip to main content
. 2019 Aug;8(4):1242–1248. doi: 10.21037/tcr.2019.07.10

Figure 2.

Figure 2

Correlation of FR+CTC with clinicopathological features. Comparison of FR+CTC levels between lung cancer patients with (A) different age; (B) different gender; (C) different pathological subtype; and (D) different clinical stage. Lines indicate the median and inter-quartile range of FR+CTC level. * indicates P<0.05. FR+CTC, folate receptor-positive circulating tumor cell.